Companies 0 See All
Hedge Funds 0 See All
Insiders 0 See All
Institutional Investors 0 See All
Click here to see all results for
Home > Insider Trading > Theravance Biopharma Inc.

Theravance Biopharma Inc. (TBPH)

Market is closed
News
What Happened To Billionaire Seth Klarman's Top Biotech Picks In The Third Quarter?

What Happened To Billionaire Seth Klarman's Top Biotech Picks In The Third Quarter?

Some investors think billionaire Seth Klarman is the next Warren Buffett. Given that Klarman's $31 billion fund, Baupost Group, has achieved average annual returns of 17% a year for over 30 years, ...

Keep Reading →

October 14th, 2015 - News

Billionaire Seth Klarman's Biotech Stock Picks

Billionaire Seth Klarman's Biotech Stock Picks

Billionaire Seth Klarman is a notorious investor who despite his uncoventional approaches always managed to achieve high returns.

Keep Reading →

March 15th, 2015 - Hedge Funds News

Insider Monkey Quarterly Strategy
+373.4% Insider Monkey Quarterly Strategy
+154.9% Benchmark50% S&P 500 ETF and 50% Russell 2000 ETF
300%
200%
100%
Subscribe Now

Returns since its inception in May 2014 (through February 19th, 2025)